Melatonin with 1,25-Dihydroxyvitamin D3 Protects against Apoptotic Ischemia–Reperfusion Injury in the Rat Kidney

REFERENCES

• Russ AL, Haberstroh KM, Rundell AE. Experimental strategies to improve in vitro models of renal ischemia. Exp Mol Pathol. 2007;83(2):143–159.
   PubMedGoogle Scholar
• Kadkhodaee M, Golab F, Zahmatkesh M, . Effects of different periods of renal ischemia on liver as a remote organ. World J Gastroenterol. 2009;15(9):1113–1118.
   PubMed Web of Science ®Google Scholar
• Witzgall R. The proximal tubule phenotype and its disruption in acute renal failure and polycystic kidney disease. Exp Nephrol. 1999;7(1):15–19.
   PubMedGoogle Scholar
• Schumer M, Colombel MC, Sawczuk IS, . Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol. 1992;140(4):831–838.
   PubMed Web of Science ®Google Scholar
• Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science. 1998;281(5381):1312–1316.
   PubMed Web of Science ®Google Scholar
• Kunduzova OR, Escourrou G, Seguelas MH, . Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J. 2003;17(8):872–874.
   PubMedGoogle Scholar
• Tunçdemir M, Oztürk M. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy. Acta Histochem. 2011;113(8):826–832.
   PubMedGoogle Scholar
• Aktoz T, Aydogdu N, Alagol B, Yalcin O, Huseyinova G, Atakan IH. The protective effects of melatonin and vitamin E against renal ischemia-reperfusion injury in rats. Ren Fail. 2007;29(5):535–542.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Reyes-Gonzales M, Fuentes-Broto L, Tan DX. Melatonin reduces oxidative catastrophe in neurons and glia. Act Nerv Super Rediviva. 2010;52(1):93–103.
   Google Scholar
• Rodriguez C, Mayo JC, Sainz RM, . Regulation of antioxidants enzymes: A significant role for melatonin. J Pineal Res. 2004;36(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ozturk G, Coşkun S, Erbaş D, Hasanoglu E. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol. 2000;50(1):149–153.
   PubMedGoogle Scholar
• Rodriguez-Reynoso S, Leal C, Portilla-de Buen E, Castillo JC, Ramos-Solano F. Melatonin ameliorates renal ischemia/reperfusion injury. J Surg Res. 2004;116(2):242–247.
   PubMed Web of Science ®Google Scholar
• Yurtcu M, Abasiyanik A, Avunduk MC, Muhtaroglu S. Effects of melatonin on spermatogenesis and testicular ischemia-reperfusion injury after unilateral testicular torsion-detorsion. J Pediatr Surg. 2008;43(10):1873–1878.
   PubMedGoogle Scholar
• Yurtcu M, Abasiyanik A, Bicer S, Avunduk MC. Efficacy of antioxidant treatment in the prevention of testicular atrophy in experimental testicular torsion. J Pediatr Surg. 2009;44(9): 1754–1758.
   PubMedGoogle Scholar
• Chu MP, Alagiakrishnan K, Sadowski C. The cure of ageing: Vitamin D-magic or myth? Postgrad Med J. 2010;86(1020):608–616.
   PubMedGoogle Scholar
• Kuhlmann A, Haas CS, Gross ML, . 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol. 2004;286(3):526–533.
   Google Scholar
• Panichi V, Migliori M, Taccola D, . Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int. 2001;60(1):87–95.
   PubMedGoogle Scholar
• Kim YO, Li C, Sun BK, . Preconditioning with 1,25-dihydroxyvitamin D3 protects against subsequent ischemia-reperfusion injury in the rat kidney. Nephron Exp Nephrol. 2005;100(2):85–94.
   Google Scholar
• Khan KA, Akram J, Fazal M. Hormonal actions of vitamin D and its role beyond just being a vitamin: A review article. Int J Med Med Sci. 2011;3(3):65–72.
   Google Scholar
• Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela S. Melatonin as a free radical scavenger: Implications for aging and age-related diseases. Ann N Y Acad Sci. 1994;719:1–12.
   PubMed Web of Science ®Google Scholar
• Tunçdemir M, Demirkesen O, Öztürk M, Atukeren P, Gümüştaş MK, Turan T. Antiapoptotic effect of angiotensin-II type-1 receptor blockade in renal tubular cells of hyperoxalouric rats. Urol Res. 2010;38(2):71–80.
   PubMedGoogle Scholar
• Chatterjee PK, Patel NS, Kvale EO, . Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61(3):862–871.
   PubMedGoogle Scholar
• Isaka Y, Kimura T, Takabatake Y. The protective role of autophagy against aging and acute ischemic injury in kidney proximal tubular cells. Autophagy. 2011;7(9):1085–1087.
   PubMed Web of Science ®Google Scholar
• Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 2009;119(5):1275–1285.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zheng X, Sun H, . Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation. 2006;82(12):1728–1732.
   PubMedGoogle Scholar
• Sainz RM, Mayo JC, Reiter RJ, Tan DX, Rodriguez C. Apoptosis in primary lymphoid organs with aging. Microsc Res Tech. 2003;62(6):524–539.
   PubMedGoogle Scholar
• Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J Pineal Res. 1993;14(4):151–168.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee SM. Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/reperfusion injury in rat liver. J Pineal Res. 2008;44(2):165–171.
   PubMedGoogle Scholar